2014 Q1 Form 10-Q Financial Statement

#000119312514190425 Filed on May 09, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q1
Revenue $204.1M $193.2M
YoY Change 5.65% 9.05%
Cost Of Revenue $110.8M $116.3M
YoY Change -4.76% 8.67%
Gross Profit $93.29M $76.83M
YoY Change 21.42% 9.64%
Gross Profit Margin 45.71% 39.77%
Selling, General & Admin $23.94M $15.63M
YoY Change 53.14% -23.51%
% of Gross Profit 25.66% 20.34%
Research & Development $10.80M $9.000M
YoY Change 20.0% -6.25%
% of Gross Profit 11.58% 11.71%
Depreciation & Amortization $7.680M $7.001M
YoY Change 9.7% 15.57%
% of Gross Profit 8.23% 9.11%
Operating Expenses $23.94M $15.63M
YoY Change 53.14% -23.51%
Operating Profit $58.57M $52.18M
YoY Change 12.25% 30.34%
Interest Expense $7.000K $14.00K
YoY Change -50.0% 180.0%
% of Operating Profit 0.01% 0.03%
Other Income/Expense, Net
YoY Change
Pretax Income $58.64M $52.28M
YoY Change 12.17% 30.27%
Income Tax $16.03M $12.44M
% Of Pretax Income 27.33% 23.79%
Net Earnings $42.62M $39.84M
YoY Change 6.97% 38.35%
Net Earnings / Revenue 20.88% 20.63%
Basic Earnings Per Share $1.05 $0.98
Diluted Earnings Per Share $1.04 $0.98
COMMON SHARES
Basic Shares Outstanding 40.68M shares 40.53M shares
Diluted Shares Outstanding 40.89M shares 40.71M shares

Balance Sheet

Concept 2014 Q1 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $420.9M $319.0M
YoY Change 31.94% 11.73%
Cash & Equivalents $420.9M $319.0M
Short-Term Investments
Other Short-Term Assets $28.32M $17.98M
YoY Change 57.48% -60.99%
Inventory $397.4M $368.3M
Prepaid Expenses
Receivables $266.1M $212.1M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.138B $942.2M
YoY Change 20.83% 13.61%
LONG-TERM ASSETS
Property, Plant & Equipment $311.5M $299.0M
YoY Change 4.16% 5.19%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.17M $10.73M
YoY Change -5.16% -11.36%
Total Long-Term Assets $321.6M $309.8M
YoY Change 3.83% 4.51%
TOTAL ASSETS
Total Short-Term Assets $1.138B $942.2M
Total Long-Term Assets $321.6M $309.8M
Total Assets $1.460B $1.252B
YoY Change 16.62% 11.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $53.60M $38.48M
YoY Change 39.3% 5.13%
Accrued Expenses $35.00M $35.20M
YoY Change -0.57% 11.75%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $156.7M $144.8M
YoY Change 8.2% -4.41%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $156.7M $144.8M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $166.3M $154.6M
YoY Change 7.56% -3.95%
SHAREHOLDERS EQUITY
Retained Earnings $1.112B $939.8M
YoY Change 18.37%
Common Stock $195.7M $185.9M
YoY Change 5.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.294B $1.097B
YoY Change
Total Liabilities & Shareholders Equity $1.460B $1.252B
YoY Change 16.62% 11.21%

Cashflow Statement

Concept 2014 Q1 2013 Q1
OPERATING ACTIVITIES
Net Income $42.62M $39.84M
YoY Change 6.97% 38.35%
Depreciation, Depletion And Amortization $7.680M $7.001M
YoY Change 9.7% 15.57%
Cash From Operating Activities $48.60M $74.98M
YoY Change -35.18% -5152.76%
INVESTING ACTIVITIES
Capital Expenditures $13.22M $12.07M
YoY Change 9.53% -12.96%
Acquisitions
YoY Change
Other Investing Activities $400.0K $200.0K
YoY Change 100.0% 0.0%
Cash From Investing Activities -$12.86M -$11.90M
YoY Change 8.06% -13.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 512.0K 3.673M
YoY Change -86.06% 575.18%
NET CHANGE
Cash From Operating Activities 48.60M 74.98M
Cash From Investing Activities -12.86M -11.90M
Cash From Financing Activities 512.0K 3.673M
Net Change In Cash 36.25M 66.75M
YoY Change -45.69% -555.65%
FREE CASH FLOW
Cash From Operating Activities $48.60M $74.98M
Capital Expenditures $13.22M $12.07M
Free Cash Flow $35.38M $62.91M
YoY Change -43.76% -509.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
40834224 shares
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
318974000
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40829349 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40829349 shares
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
17748000
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
53597000
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
156688000
CY2014Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
17288000
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-14441000
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
1293705000
CY2014Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
195305000
CY2014Q1 us-gaap Billings In Excess Of Cost
BillingsInExcessOfCost
52870000
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1112434000
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
407000
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1460049000
CY2014Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
9656000
CY2014Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
34237000
CY2014Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
15185000
CY2014Q1 us-gaap Liabilities
Liabilities
166344000
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q1 us-gaap Assets Current
AssetsCurrent
1138404000
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10172000
CY2014Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
91514000
CY2014Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
120426000
CY2014Q1 us-gaap Unbilled Receivables Not Billable At Balance Sheet Date Amount Expected To Be Collected Within One Year
UnbilledReceivablesNotBillableAtBalanceSheetDateAmountExpectedToBeCollectedWithinOneYear
60000000
CY2014Q1 us-gaap Assets
Assets
1460049000
CY2014Q1 us-gaap Noncurrent Assets
NoncurrentAssets
321645000
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
420938000
CY2014Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
266086000
CY2014Q1 us-gaap Inventory Net
InventoryNet
397356000
CY2014Q1 us-gaap Inventory Gross
InventoryGross
431593000
CY2014Q1 us-gaap Other Assets Current
OtherAssetsCurrent
28322000
CY2014Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
25702000
CY2014Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
219653000
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
311473000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
257191000
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40822627 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40822627 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
23780000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
38801000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
142790000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
21556000
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-20170000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
1242018000
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
191965000
CY2013Q4 us-gaap Billings In Excess Of Cost
BillingsInExcessOfCost
45025000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1069816000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
407000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1394612000
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
9804000
CY2013Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
33216000
CY2013Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
13628000
CY2013Q4 us-gaap Liabilities
Liabilities
152594000
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40529000 shares
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Assets Current
AssetsCurrent
1078813000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10993000
CY2013Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
85670000
CY2013Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
119929000
CY2013Q4 us-gaap Unbilled Receivables Not Billable At Balance Sheet Date Amount Expected To Be Collected Within One Year
UnbilledReceivablesNotBillableAtBalanceSheetDateAmountExpectedToBeCollectedWithinOneYear
52900000
CY2013Q4 us-gaap Assets
Assets
1394612000
CY2013Q4 us-gaap Noncurrent Assets
NoncurrentAssets
315799000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
384356000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
279253000
CY2013Q4 us-gaap Inventory Net
InventoryNet
368354000
CY2013Q4 us-gaap Inventory Gross
InventoryGross
401570000
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
21899000
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
24951000
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
195971000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
304806000
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.98
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40713000 shares
CY2013Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
184000 shares
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.98
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
74983000
CY2013Q1 us-gaap Revenues
Revenues
193155000
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
25219000
CY2013Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-14623000
CY2013Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
160485000
CY2013Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-434000
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
606000
CY2013Q1 us-gaap Interest Income Other
InterestIncomeOther
116000
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
52177000
CY2013Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
32670000
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
52279000
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-46162000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
39842000
CY2013Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
11683000
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12070000
CY2013Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7116000
CY2013Q1 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
166000
CY2013Q1 us-gaap Costs And Expenses
CostsAndExpenses
140978000
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3673000
CY2013Q1 us-gaap Cost Of Services
CostOfServices
19655000
CY2013Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
96673000
CY2013Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1142000
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2091000
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
61783000
CY2013Q1 us-gaap Interest Expense
InterestExpense
14000
CY2013Q1 us-gaap Cost Of Revenue
CostOfRevenue
116328000
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11904000
CY2013Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3067000
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7001000
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
606000
CY2013Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15629000
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12437000
CY2013Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-4969000
CY2013Q1 drq Engineering And Product Development
EngineeringAndProductDevelopment
9021000
CY2013Q1 drq Number Of Projects
NumberOfProjects
14 Project
CY2013Q1 drq Reporting Information Eliminations
ReportingInformationEliminations
12673000
CY2013Q1 drq Percentage Of Product Revenue
PercentageOfProductRevenue
0.22 pure
CY2013Q1 drq Allocated Share Based Compensation Expense Capitalized
AllocatedShareBasedCompensationExpenseCapitalized
0
CY2013Q1 drq Percentage Of Cumulative Revenue
PercentageOfCumulativeRevenue
0.19 pure
CY2013Q1 drq Revenue From Inter Company Transactions
RevenueFromInterCompanyTransactions
12673000
CY2014Q1 dei Trading Symbol
TradingSymbol
DRQ
CY2014Q1 dei Entity Registrant Name
EntityRegistrantName
DRIL-QUIP INC
CY2014Q1 dei Amendment Flag
AmendmentFlag
false
CY2014Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2014Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q1 dei Document Type
DocumentType
10-Q
CY2014Q1 dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
CY2014Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001042893
CY2014Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q1 us-gaap Revenue Recognition Sales Of Goods
RevenueRecognitionSalesOfGoods
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 2%; MARGIN-TOP: 18pt"> <i>Revenue Recognition</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 6pt"> <i>Product Revenue</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The Company earns product revenues from two methods:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="5%">&#xA0;</td> <td valign="top" width="2%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">product revenues recognized under the percentage-of-completion method; and</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="5%">&#xA0;</td> <td valign="top" width="2%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">product revenues from the sale of products that do not qualify for the percentage-of-completion method.</td> </tr> </table> </div>
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.04
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40887000 shares
CY2014Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
209000 shares
CY2014Q1 us-gaap Revenue Recognition Sales Of Services
RevenueRecognitionSalesOfServices
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 2%; MARGIN-TOP: 18pt"> <i>Service revenue</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The Company earns service revenues from three sources:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="5%">&#xA0;</td> <td valign="top" width="2%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">technical advisory assistance;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="5%">&#xA0;</td> <td valign="top" width="2%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">rental of running tools; and</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="5%">&#xA0;</td> <td valign="top" width="2%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">rework and reconditioning of customer-owned Dril-Quip products.</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> The Company does not install products for its customers, but it does provide technical advisory assistance. At the time of delivery of the product, the customer is not obligated to buy or rent the Company&#x2019;s running tools and the Company is not obligated to perform any subsequent services relating to installation. Technical advisory assistance service revenue is recorded at the time the service is rendered. Service&#xA0;revenues associated with the rental of running and installation tools are recorded as earned. Rework and reconditioning service revenues are recorded when the refurbishment process is complete.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> The Company normally negotiates contracts for products, including those accounted for under the percentage-of-completion method, and services separately. For all product sales, it is the customer&#x2019;s decision as to the timing of the product installation as well as whether Dril-Quip running tools will be purchased or rented. Furthermore, the customer is under no obligation to utilize the Company&#x2019;s technical advisory services. The customer may use a third party or their own personnel.</p> </div>
CY2014Q1 us-gaap Revenue Recognition Percentage Of Completion Method
RevenueRecognitionPercentageOfCompletionMethod
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 2%; MARGIN-TOP: 18pt"> <i>Revenues recognized under the percentage-of-completion method</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The Company uses the percentage-of-completion method on long-term project contracts that have the following characteristics:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="5%">&#xA0;</td> <td valign="top" width="2%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">The contracts call for products which are designed to customer specifications;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 6px"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="5%">&#xA0;</td> <td valign="top" width="2%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">The structural designs are unique and require significant engineering and manufacturing efforts generally requiring more than one year in duration;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="5%">&#xA0;</td> <td valign="top" width="2%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">The contracts contain specific terms as to milestones, progress billings and delivery dates; and</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="5%">&#xA0;</td> <td valign="top" width="2%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">Product requirements cannot be filled directly from the Company&#x2019;s standard inventory.</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> For each project, the Company prepares a detailed analysis of estimated costs, profit margin, completion date and risk factors which include availability of material, production efficiencies and other factors that may impact the project. On a quarterly basis, management reviews the progress of each project, which may result in revisions of previous estimates, including revenue recognition. The Company calculates the percent complete and applies the percentage to determine the revenues earned and the appropriate portion of total estimated costs. Losses, if any, are recorded in full in the period they become known. Historically, the Company&#x2019;s estimates of total costs and costs to complete have approximated actual costs incurred to complete the project.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> Under the percentage-of-completion method, billings may not correlate directly to the revenue recognized. Based upon the terms of the specific contract, billings may be in excess of the revenue recognized, in which case the amounts are included in customer prepayments as a liability on the Condensed Consolidated Balance Sheets. Likewise, revenue recognized may exceed customer billings in which case the amounts are reported in trade receivables. Unbilled revenues are expected to be billed and collected within one year. At March&#xA0;31, 2014 and December&#xA0;31, 2013, receivables included $60.0 million and $52.9 million of unbilled receivables, respectively. For the quarter ended March&#xA0;31, 2014, there were 15 projects representing approximately 12% of the Company&#x2019;s total revenue and approximately 14% of its product revenues that were accounted for using percentage-of-completion accounting, compared to 14 such projects during the first quarter of 2013, which represented approximately 19% of the Company&#x2019;s total revenues and approximately 22% of its product revenues.</p> </div>
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.05
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
48603000
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40678000 shares
CY2014Q1 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 2%; MARGIN-TOP: 18pt"> <i>Use of Estimates</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Some of the Company&#x2019;s more significant estimates are those affected by critical accounting policies for revenue recognition, inventories and contingent liabilities as discussed more fully in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#xA0;31, 2013.</p> </div>
CY2014Q1 us-gaap Revenues
Revenues
204073000
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
48347000
CY2014Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
5729000
CY2014Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
172001000
CY2014Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5096000
CY2014Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
49000
CY2014Q1 us-gaap Interest Income Other
InterestIncomeOther
83000
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
58567000
CY2014Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
32072000
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
58643000
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-14680000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
42618000
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
26333000
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13220000
CY2014Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
13146000
CY2014Q1 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
356000
CY2014Q1 us-gaap Costs And Expenses
CostsAndExpenses
145506000
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
512000
CY2014Q1 us-gaap Cost Of Services
CostOfServices
19456000
CY2014Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
91331000
CY2014Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-869000
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2826000
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
36582000
CY2014Q1 us-gaap Interest Expense
InterestExpense
7000
CY2014Q1 us-gaap Cost Of Revenue
CostOfRevenue
110787000
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12864000
CY2014Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
463000
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7680000
CY2014Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
49000
CY2014Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
23935000
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16025000
CY2014Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
331000
CY2014Q1 drq Number Of Service Revenue Sources
NumberOfServiceRevenueSources
3 Source
CY2014Q1 drq Engineering And Product Development
EngineeringAndProductDevelopment
10784000
CY2014Q1 drq Number Of Projects
NumberOfProjects
15 Project
CY2014Q1 drq Number Of Product Revenue Sources
NumberOfProductRevenueSources
2 Method
CY2014Q1 drq Number Of Geographic Segments
NumberOfGeographicSegments
3 Segment
CY2014Q1 drq Reporting Information Eliminations
ReportingInformationEliminations
11834000
CY2014Q1 drq Percentage Of Product Revenue
PercentageOfProductRevenue
0.14 pure
CY2014Q1 drq Allocated Share Based Compensation Expense Capitalized
AllocatedShareBasedCompensationExpenseCapitalized
0
CY2014Q1 drq Percentage Of Cumulative Revenue
PercentageOfCumulativeRevenue
0.12 pure
CY2014Q1 drq Revenue From Inter Company Transactions
RevenueFromInterCompanyTransactions
11834000

Files In Submission

Name View Source Status
0001193125-14-190425-index-headers.html Edgar Link pending
0001193125-14-190425-index.html Edgar Link pending
0001193125-14-190425.txt Edgar Link pending
0001193125-14-190425-xbrl.zip Edgar Link pending
d700570d10q.htm Edgar Link pending
d700570dex311.htm Edgar Link pending
d700570dex312.htm Edgar Link pending
d700570dex321.htm Edgar Link pending
d700570dex322.htm Edgar Link pending
drq-20140331.xml Edgar Link completed
drq-20140331.xsd Edgar Link pending
drq-20140331_cal.xml Edgar Link unprocessable
drq-20140331_def.xml Edgar Link unprocessable
drq-20140331_lab.xml Edgar Link unprocessable
drq-20140331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending